Literature DB >> 11595990

Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections.

M Velasco1, J P Horcajada, J Mensa, A Moreno-Martinez, J Vila, J A Martinez, J Ruiz, M Barranco, G Roig, E Soriano.   

Abstract

Quinolone-resistant (QR) Escherichia coli may have lower invasive capacity than does quinolone-susceptible E. coli. To evaluate this, we prospectively collected data regarding all cases of E. coli invasive urinary tract infections (IUTI) in 669 adults admitted to the Infectious Diseases Unit of our hospital during a 3-year period, as well as 10,950 patients with cystitis or asymptomatic bacteriuria who presented to the outpatient clinic during a 1-year period. QR E. coli was isolated in 20% of patients with cystitis, compared with 8% of those with IUTI (P<.05). The proportion of E. coli isolates that were quinolone resistant was similar in patients with bacteremic and nonbacteremic IUTI. The factors of urinary manipulation and structural abnormalities were independently associated with the presence of quinolone resistance. Old age was the only variable independently associated with blood invasion. QR E. coli is less likely to produce invasive disease (pyelonephritis and prostatitis) than is quinolone-susceptible E. coli. However, once pyelonephritis or prostatitis have developed, there is no difference in the incidence of bacteremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595990     DOI: 10.1086/323810

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.

Authors:  Priscila Reina Siliano; Lillian Andrade Rocha; José Osmar Medina-Pestana; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

3.  Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.

Authors:  Jonas Marschall; Lixin Zhang; Betsy Foxman; David K Warren; Jeffrey P Henderson
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

4.  Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.

Authors:  Johann D D Pitout; Kevin B Laupland; Deirdre L Church; Megan L Menard; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high.

Authors:  Jae Hyun Jeon; Kyuseok Kim; Woong Dae Han; Sang Hoon Song; Kyoung Un Park; Joong Eui Rhee; Kyoung-Ho Song; Wan Beom Park; Eu Suk Kim; Sang Won Park; Nam Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

7.  Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Authors:  Juan P Horcajada; Sara Soto; Abby Gajewski; Alex Smithson; M Teresa Jiménez de Anta; Josep Mensa; Jordi Vila; James R Johnson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.

Authors:  A Smithson; C Chico; J Ramos; C Netto; M Sanchez; J Ruiz; R Porron; M T Bastida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-15       Impact factor: 3.267

9.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.